John Castle
5Patents
2h-index
17Co-inventors
44Inventor score
Filing activity: Jun 3, 2005 → Jul 2, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10738355B2 | Individualized vaccines for cancer | Emerging Cross-Sectional Technologies | 35 | Active |
| US11222711B2 | Predicting immunogenicity of T cell epitopes | Chemistry; Metallurgy | 9 | Active |
| US11248264B2 | Individualized vaccines for cancer | Emerging Cross-Sectional Technologies | 2 | Active |
| US7150969B2 | Alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2) | Chemistry; Metallurgy | 0 | Expired |
| US10568948B2 | Vaccines for treatment and prevention of cancer | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.